Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate Posted byZacks Equity Research September 28, 2021 Leave a comment on Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate Incyte (INCY) collaborates with Syndax to develop and commercialize axatilimab for chronic graft-versus-host disease and other fibrotic diseases.